9WM
BMY icon

9258 Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

9258 Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$807K Sell
15,596
-1,800
-10% -$84.4K 0.12% 141
2024
Q2 		$722K Sell
17,396
-2,802
-14% -$125K 0.11% 153
2024
Q1 		$1.1M Sell
20,198
-358
-2% -$18.2K 0.17% 112
2023
Q4 		$1.05M Sell
20,556
-1,495
-7% -$78.5K 0.19% 108
2023
Q3 		$1.28M Sell
22,051
-507
-2% -$31.1K 0.25% 80
2023
Q2 		$1.44M Sell
22,558
-265
-1% -$17.8K 0.27% 74
2023
Q1 		$1.58M Buy
22,823
+585
+3% +$41.3K 0.32% 64
2022
Q4 		$1.6M Sell
22,238
-1,435
-6% -$108K 0.35% 66
2022
Q3 		$1.68M Sell
23,673
-1,299
-5% -$94.2K 0.43% 53
2022
Q2 		$1.92M Sell
24,972
-1,005
-4% -$76.5K 0.49% 49
2022
Q1 		$1.9M Buy
25,977
+133
+0.5% +$8.93K 0.44% 45
2021
Q4 		$1.61M Sell
25,844
-936
-3% -$54.9K 0.37% 51
2021
Q3 		$1.58M Sell
26,780
-716
-3% -$47.2K 0.42% 44
2021
Q2 		$1.84M Buy
27,496
+384
+1% +$25K 0.49% 33
2021
Q1 		$1.71M Buy
27,112
+1,555
+6% +$96.7K 0.51% 33
2020
Q4 		$1.58M Buy
25,557
+3,037
+13% +$187K 0.52% 36
2020
Q3 		$1.32M Buy
22,520
+901
+4% +$54.2K 0.5% 38
2020
Q2 		$1.27M Buy
21,619
+401
+2% +$24K 0.52% 38
2020
Q1 		$1.33M Buy
21,218
+1,394
+7% +$85.2K 0.58% 34
2019
Q4 		$1.27M Buy
19,824
+1,919
+11% +$110K 0.47% 52
2019
Q3 		$908K Buy
17,905
+2,644
+17% +$124K 0.71% 44
2019
Q2 		$692K Buy
15,261
+6,508
+74% +$303K 0.56% 58
2019
Q1 		$418K Buy
8,753
+1,335
+18% +$66.5K 0.36% 94
2018
Q4 		$386K Buy
+7,418
New +$399K 0.37% 89

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

9258 Wealth Management's BMY Position: Q3 2024 in Review

9258 Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2024, selling an estimated $84.4K and leaving 15,596 shares worth $807K. The position accounts for 0.12% of the portfolio, ranked #141.

9258 Wealth Management first reported a position in BMY in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.92M in Q2 2022. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • 9258 Wealth Management held 15,596 shares of Bristol-Myers Squibb worth $807K as of Q3 2024.
  • 9258 Wealth Management sold 1,800 Bristol-Myers Squibb shares in Q3 2024, an estimated $84.4K.
  • Bristol-Myers Squibb made up 0.12% of 9258 Wealth Management's portfolio in Q3 2024, its #141 holding.
  • 9258 Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 24 quarters since.
  • 9258 Wealth Management's Bristol-Myers Squibb position peaked at $1.92M in Q2 2022.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.